Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huiyinbi Group, specifically through its subsidiary Zhejiang Qiqi Pharmaceutical, is a Chinese pharmaceutical enterprise focused on the research, development, and manufacturing of both traditional Chinese medicines (TCM) and modern chemical drugs. The company operates large-scale production facilities that are GMP-certified for various dosage forms, including tablets, capsules, granules, and oral liquids. Its product portfolio primarily targets gastrointestinal health, respiratory conditions, and cardiovascular wellness. Huiyinbi Group integrates raw material cultivation, processing, and finished product distribution to maintain a comprehensive supply chain within the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huiyinbi Group Zhejiang Qiqi Pharmaceutical.